# Remodeling of the Mouse Liver and Skeletal Muscle Metabolome in Response to Continuous Acute Exercise and Disruption of AMPK-Glycogen Interactions

**Authors:** Mehdi R. Belhaj, David I. Broadhurst, Thomas Dignan, Jamie Whitfield, Lisa Murray-Segal, Naomi X. Y. Ling, Jonathan S. Oakhill, Bruce E. Kemp, John A. Hawley, Stacey N. Reinke, Nolan J. Hoffman

PMC · DOI: 10.3390/metabo16030205 · Metabolites · 2026-03-20

## TL;DR

This study explores how continuous acute exercise and disrupted AMPK-glycogen interactions affect liver and muscle metabolism in mice, revealing new metabolites involved in these processes.

## Contribution

The study identifies novel metabolites and pathways regulated by acute exercise and AMPK-glycogen interactions in mouse liver and skeletal muscle.

## Key findings

- Over 200 metabolites were identified, with 45 showing significant response to exercise.
- Exercise-regulated metabolites included ergothioneine and N6,N6,N6-trimethyl-L-lysine.
- Differential metabolite responses in DKI mice suggest impaired metabolic control and exercise capacity.

## Abstract

Background/Objectives: Acute exercise remodels many interconnected biochemical pathways in metabolically active tissues. This remodeling involves the activation of the energy-sensing AMP-activated protein kinase (AMPK) to maintain cellular energy homeostasis. Critical energy reserves of glycogen, primarily stored in liver and skeletal muscle and known to interact with AMPK, are utilized to help meet increased energy demands with exercise. However, the breadth of metabolic pathways regulated by acute exercise and AMPK’s interactive roles with glycogen remain incompletely understood. This study therefore aimed to map mouse liver and skeletal muscle metabolite responses to continuous acute exercise and disruption of AMPK-glycogen interactions. Methods: Liquid chromatography–mass spectrometry-based untargeted metabolomics was used to measure the relative abundance of liver and gastrocnemius muscle metabolites at rest and following an acute bout of continuous treadmill running in wild type (WT) and AMPK transgenic mice with double knock-in (DKI) mutations in the β subunit carbohydrate binding module that mediates glycogen binding. Results: Over 200 total metabolites were identified/annotated across liver and skeletal muscle, including 45 metabolites responsive to exercise (p < 0.05; FDR < 0.1). Exercise-regulated metabolites included known metabolic pathways and metabolites never associated or with only emerging evidence related to exercise (e.g., ergothioneine) and/or AMPK-glycogen interactions (N6,N6,N6-trimethyl-L-lysine, a precursor of L-carnitine). Conclusions: Liver and skeletal muscle metabolomic profiles displayed shifts between WT and DKI mice at rest, with shifts also detected following a continuous acute exercise bout. An interaction effect was also observed in skeletal muscle, suggesting differential muscle metabolite responses to acute exercise in DKI mice that may contribute to their functional impairments in metabolic control and exercise capacity versus WT. Collectively, these findings expand the molecular landscape of acute exercise and reveal liver and muscle metabolites underlying exercise-induced metabolic responses.

## Linked entities

- **Proteins:** PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1)
- **Chemicals:** ergothioneine (PubChem CID 5351619), N6,N6,N6-trimethyl-L-lysine (PubChem CID 440120), L-carnitine (PubChem CID 288)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Prkab1 (protein kinase, AMP-activated, beta 1 non-catalytic subunit) [NCBI Gene 19079] {aka 1300015D22Rik, E430008F22}, Slc2a4 (solute carrier family 2 (facilitated glucose transporter), member 4) [NCBI Gene 20528] {aka GT2, Glut-4, Glut4, twgy}, Hbb-b1 (hemoglobin, beta adult major chain) [NCBI Gene 15129] {aka Hbb1, Hbbt1, Hbbt2, MommeD7, beta1}, Bdkrb2 (bradykinin receptor, beta 2) [NCBI Gene 12062] {aka B(2), B2, B2R, BK-2, BK2, BK2R}, Prkab2 (protein kinase, AMP-activated, beta 2 non-catalytic subunit) [NCBI Gene 108097] {aka 5730553K21Rik}, Cpt1b (carnitine palmitoyltransferase 1b, muscle) [NCBI Gene 12895] {aka Cpt1, Cpt1-m, Cpti, Cpti-m, M-cpti}
- **Diseases:** DKI (MESH:D056304), glucose intolerance (MESH:D018149), obesity (MESH:D009765), insulin resistance (MESH:D007333), injury to (MESH:D014947), inflammation (MESH:D007249), adiposity (MESH:D018205), impaired liver health (MESH:D017093), liver disease (MESH:D008107)
- **Chemicals:** tryptophan (MESH:D014364), hypotaurine (MESH:C003949), hexanoylcarnitine (MESH:C061301), B (MESH:D001895), isoflavone (MESH:D007529), starch (MESH:D013213), lipid (MESH:D008055), fat (MESH:D005223), CDP-choline (MESH:D003566), disaccharide (MESH:D004187), TCA (MESH:D014238), blebbistatin (MESH:C472645), Creatine phosphate (MESH:D010725), triacylglycerol (MESH:D014280), ADP (MESH:D000244), A (MESH:D001151), cystathionine (MESH:D003540), adenosine (MESH:D000241), N6,N6,N6-trimethyl-L-lysine (MESH:C003712), Ergothioneine (MESH:D004880), stachyose (MESH:C005695), hypoxanthine (MESH:D019271), Carnitine (MESH:D002331), O2 (MESH:D010100), AMP (MESH:D000249), fatty acid (MESH:D005227), C (MESH:D002244), xanthine (MESH:D019820), tricarboxylic acid (MESH:D014233), imidazole (MESH:C029899), serine (MESH:D012694), creatine (MESH:D003401), Glycerol-3-phosphate (MESH:C029620), CaK2EGTA (-), deoxycholic acid (MESH:D003840), purine (MESH:C030985), cortisol (MESH:D006854), alanine (MESH:D000409), hydrogen sulfide (MESH:D006862), EGTA (MESH:D004533), MES (MESH:C004550), propionylcarnitine (MESH:C003223), palmitoylcarnitine (MESH:D010172), ammonium formate (MESH:C030544), maltotriose (MESH:C008317), melatonin (MESH:D008550), glucose (MESH:D005947), nitrogen (MESH:D009584), malate (MESH:C030298), Daidzein (MESH:C004742), P (MESH:D010758), NEFA (MESH:D005230), water (MESH:D014867), decanoylcarnitine (MESH:C002893), DTT (MESH:D004229), glycine (MESH:D005998), acylcarnitines (MESH:C116917), CO2 (MESH:D002245), carbohydrate (MESH:D002241), taurine (MESH:D013654)
- **Species:** Homo sapiens (human, species) [taxon 9606], Glycine max (soybean, species) [taxon 3847], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** W98A, W100A
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028007/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028007/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028007/full.md

---
Source: https://tomesphere.com/paper/PMC13028007